rs201487919
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004281.4(BAG3):c.574G>A(p.Gly192Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G192C) has been classified as Uncertain significance.
Frequency
Consequence
NM_004281.4 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1HHInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- myofibrillar myopathyInheritance: AD Classification: DEFINITIVE Submitted by: G2P, ClinGen
- myofibrillar myopathy 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-tooth disease, axonal, type 2JJInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- distal hereditary motor neuropathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BAG3 | ENST00000369085.8 | c.574G>A | p.Gly192Ser | missense_variant | Exon 3 of 4 | 1 | NM_004281.4 | ENSP00000358081.4 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152076Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000761 AC: 19AN: 249790 AF XY: 0.0000517 show subpopulations
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461796Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727218 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74430 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
The BAG3 c.574G>A; p.Gly192Ser variant (rs201487919), to our knowledge, is not reported in the medical literature but is reported as uncertain in ClinVar (Variation ID: 471803). This variant is found in the East Asian population with an allele frequency of 0.04% (7/19,920 alleles) in the Genome Aggregation Database. The glycine at codon 192 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, given the lack of clinical and functional data, the significance of the p.Gly192Ser variant is uncertain at this time. -
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Uncertain:1Benign:1
- -
- -
Cardiovascular phenotype Uncertain:1
The p.G192S variant (also known as c.574G>A), located in coding exon 3 of the BAG3 gene, results from a G to A substitution at nucleotide position 574. The glycine at codon 192 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at